Cargando…

Circulating Matrix Metalloproteinase-28 Levels Are Related to GRACE Scores and Short-Term Outcomes in Patients with Acute Myocardial Infarction

OBJECTIVE: To investigate the relationship between the level of matrix metalloproteinase-28 (MMP-28) in patients with acute myocardial infarction (AMI) and the global registry of acute coronary events (GRACE) scores as well as their short-term prognosis. METHODS: Two hundred eleven patients with AMI...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Ke, Li, Yuanmin, Xu, Yawei, Guo, Rong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273487/ https://www.ncbi.nlm.nih.gov/pubmed/32596395 http://dx.doi.org/10.1155/2020/9206703

Ejemplares similares

Correlation Between Plasma Matrix Metalloproteinase-28 Levels and Severity of Calcific Aortic Valve Stenosis
por: Zhou, Ke, et al.
Publicado: (2020)

External validation of the GRACE risk score in patients with myocardial infarction in Hungary
por: Ferenci, Tamás, et al.
Publicado: (2023)

Prognostic Value of TIMI Score versus GRACE Score in ST-segment Elevation Myocardial Infarction
por: Correia, Luis C. L., et al.
Publicado: (2014)

Frailty assessment and risk prediction by GRACE score in older patients with acute myocardial infarction
por: Anand, Atul, et al.
Publicado: (2020)

GRACE 2.0 Score for Risk Prediction in Myocardial Infarction With Nonobstructive Coronary Arteries
por: Eggers, Kai M., et al.
Publicado: (2021)

Interleukin-33, matrix metalloproteinase-9, and tissue ınhibitor of matrix metalloproteinase-1 in myocardial infarction
por: Guzel, Savas, et al.
Publicado: (2013)

Matrix metalloproteinases in coronary artery disease and myocardial infarction
por: Bräuninger, Hanna, et al.
Publicado: (2023)

Homocysteine enhances the predictive value of the GRACE risk score in patients with ST-elevation myocardial infarction
por: Fan, Yan, et al.
Publicado: (2017)

Performance of the GRACE 2.0 score in patients with type 1 and type 2 myocardial infarction
por: Hung, John, et al.
Publicado: (2020)

The GRACE risk score in patients with ST-segment elevation myocardial infarction and concomitant COVID-19
por: Wójcik, Mariusz, et al.
Publicado: (2022)

Erratum: Interleukin-33, matrix metalloproteinase-9, and tissue inhibitor of matrix metalloproteinase-1 in myocardial infarction
por: Guzel, Savas, et al.
Publicado: (2013)

Guideline-indicated treatments and diagnostics, GRACE risk score, and survival for non-ST elevation myocardial infarction
por: Hall, Marlous, et al.
Publicado: (2018)

Dataset on blood biomarkers and GRACE score measured at admission for myocardial infarction in a large secondary hospital
por: van den Berg, Victor J., et al.
Publicado: (2018)

Comparison of the modified Singapore myocardial infarction registry risk score with GRACE 2.0 in predicting 1-year acute myocardial infarction outcomes
por: Sia, Ching-Hui, et al.
Publicado: (2022)

A Novel Biomarker Scoring System Alone or in Combination with the GRACE Score for the Prognostic Assessment in Non-ST-Elevation Myocardial Infarction
por: Yao, Yao, et al.
Publicado: (2022)

Expression and function of matrix metalloproteinase (MMP)-28
por: Rodgers, Ursula R., et al.
Publicado: (2009)

Prognostic Value of GRACE Risk Scores in Patients With Non-ST-Elevation Myocardial Infarction With Non-obstructive Coronary Arteries
por: Yin, Guoqing, et al.
Publicado: (2021)

Clinical impact of estimated plasma volume status and its additive effect with the GRACE risk score on in-hospital and long-term mortality for acute myocardial infarction
por: Kawai, Tsutomu, et al.
Publicado: (2021)

Comparison of GRACE and TIMI risk scores in the prediction of in-hospital and long-term outcomes among East Asian non-ST-elevation myocardial infarction patients
por: Yanqiao, Lu, et al.
Publicado: (2022)

Matrix metalloproteinases and their gene polymorphism in young ST-segment elevation myocardial infarction
por: Basia, Deepak, et al.
Publicado: (2022)

Predictive values of D-dimer assay, GRACE scores and TIMI scores for adverse outcome in patients with non-ST-segment elevation myocardial infarction
por: Satilmisoglu, Muhammet Hulusi, et al.
Publicado: (2017)

Admission high‐sensitivity C‐reactive protein levels improve the Grace risk score prediction on in‐hospital outcomes in acute myocardial infarction patients
por: Lin, Xiao Long, et al.
Publicado: (2022)

Circulating Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Cardiac Amyloidosis
por: Tanaka, Komei, et al.
Publicado: (2013)

Independent Predictors of Mortality in COVID-19 Myocardial Injury: The Role of Troponin Levels, GRACE Score, SOFA Score, and TIMI Score
por: Raj, Kavin, et al.
Publicado: (2022)

Genetic Polymorphism of Matrix Metalloproteinase-9 and Susceptibility to Myocardial Infarction: A Meta-Analysis
por: Feng, Beili, et al.
Publicado: (2022)

Matrix Metalloproteinase 28-Bearing Microcystic Adnexal Carcinoma on the Back
por: Chiba, Hiromu, et al.
Publicado: (2021)

Significance of fragmented QRS complexes for identifying culprit lesions in patients with non-ST-elevation myocardial infarction: a single-center, retrospective analysis of 183 cases
por: Guo, Rong, et al.
Publicado: (2012)

Myocardial Injury Promotes Matrix Metalloproteinase-9 Activity in the Renal Cortex in Preclinical Models of Acute Myocardial Infarction
por: Qiao, Xiaoying, et al.
Publicado: (2021)

Addition of Plasma Myeloperoxidase and Trimethylamine N-Oxide to the GRACE Score Improves Prediction of Near-Term Major Adverse Cardiovascular Events in Patients With ST-Segment Elevation Myocardial Infarction
por: Tan, Yu, et al.
Publicado: (2021)

Prospective study of matrix metalloproteinase-9 and risk of myocardial infarction and stroke in older men and women
por: Jefferis, Barbara J., et al.
Publicado: (2010)

Matrix metalloproteinase 28, a novel matrix metalloproteinase, is constitutively expressed in human intervertebral disc tissue and is present in matrix of more degenerated discs
por: Gruber, Helen E, et al.
Publicado: (2009)

Short-Term Prognostic Value of the Culprit-SYNTAX Score in Patients with Acute Myocardial Infarction
por: Peker, Tezcan, et al.
Publicado: (2023)

Validation of the GRACE score risk in our population
por: Sayagues, L, et al.
Publicado: (2013)

Epilysin (matrix metalloproteinase-28) contributes to airway epithelial cell survival
por: Manicone, Anne M, et al.
Publicado: (2011)

Prognostic value of tissue inhibitor of metalloproteinase-matrix metalloproteinase biomarkers at 30 days in patients with acute myocardial infarction without reperfusion therapy
por: Pang, Hui-Fang, et al.
Publicado: (2021)

Matrix metalloproteinase 28 is regulated by TRIF- and type I IFN-dependent signaling in macrophages
por: Long, Matthew E., et al.
Publicado: (2018)

GRACE Score among Six Risk Scoring Systems (CADILLAC, PAMI, TIMI, Dynamic TIMI, Zwolle) Demonstrated the Best Predictive Value for Prediction of Long-Term Mortality in Patients with ST-Elevation Myocardial Infarction
por: Littnerova, Simona, et al.
Publicado: (2015)

Furin Functions as a Nonproteolytic Chaperone for Matrix Metalloproteinase-28: MMP-28 Propeptide Sequence Requirement
por: Pavlaki, Maria, et al.
Publicado: (2011)

Comparison of Mortality Prediction by the GRACE Score, Multiple Biomarkers, and Their Combination in All-comer Patients with Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
por: Kawamura, Yota, et al.
Publicado: (2022)

Expression of matrix metalloproteinases-12 in ST-segment elevation myocardial infarction: A case–control study
por: Wang, Jing, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_fempdvsef6j7dr2n0q5ck2amk5